(3R,5S)-3,5-piperidinediyldimethanol hydrochloride, 95.0%, 250mg

Butyl 4-Hydroxybenzoate [for Biochemical Research]>99.0%(GC)(T)5g

2-Methyl-2-phenylpropane-1,3-diol, 95+%, 1g

2-Naphthaleneboronic Acid (contains varying amounts of Anhydride)1g

2-Imidazol-1-yl-ethylamine, 95.0%, 250mg

(4S,4'S)-4,4'-Diisopropyl-1,1'-bis(3-(trifluoromethyl)phenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 1g

2-ethoxy-4-{[(2-methylpropyl)amino]methyl}phenol, 95.0%, 10g

Hexatriacontane, 98+%, 100g

FAM test liquid C, lower phase containing methanol, 500 ml, glass packaging

4-(Chlorophenyl)-4-hydroxypiperidine, 97.0%, 100g

2-N-Boc-3-(3-Bromo-phenyl)-2-methylaminomethyl-propionic acid, 97.0%, 1g

3-Iodo-7-methylimidazo[1,2-a]pyridine, 250mg

Methyl 2-amino-5-fluoro-3-nitrobenzoate, 95.0%, 5g